FCBT
ACOR

First Citizens Bank & Trust’s Acorda Therapeutics ACOR Stock Holding History

First Citizens Bank & Trust’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-115
Closed -$366K – 495
2016
Q1 		$366K Buy
+115
New +$477K 0.03% 344

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

First Citizens Bank & Trust's ACOR Position: Q2 2016 in Review

First Citizens Bank & Trust sold out of Acorda Therapeutics (ACOR) in Q2 2016, closing a stake of 115 shares — an estimated $366K sold.

First Citizens Bank & Trust first reported a position in ACOR in Q1 2016 and held it in 1 quarter. The position peaked at $366K in Q1 2016. 175 funds tracked by Wall St. Rank hold ACOR as of Q2 2016.

  • First Citizens Bank & Trust reported no remaining Acorda Therapeutics position as of Q2 2016 after selling out during the quarter.
  • First Citizens Bank & Trust sold 115 Acorda Therapeutics shares in Q2 2016, an estimated $366K.
  • First Citizens Bank & Trust first reported a position in Acorda Therapeutics in Q1 2016 and held it in 1 quarter.
  • First Citizens Bank & Trust's Acorda Therapeutics position peaked at $366K in Q1 2016.
  • 175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2016.

Based on First Citizens Bank & Trust's 13F filing for Q2 2016, filed 28 Jul 2016.